Key statistics
On Friday, XOMA Royalty Corp (XOMAP:NMQ) closed at 25.65, -3.13% below its 52-week high of 26.48, set on Jul 01, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 25.80 |
---|---|
High | 25.80 |
Low | 25.60 |
Bid | 25.01 |
Offer | 28.72 |
Previous close | 25.85 |
Average volume | 2.45k |
---|---|
Shares outstanding | 11.70m |
Free float | 11.64m |
P/E (TTM) | -- |
Market cap | 329.95m USD |
EPS (TTM) | -2.22 USD |
Annual div (ADY) | 2.16 USD |
---|---|
Annual div yield (ADY) | 8.41% |
Div ex-date | Jul 03 2024 |
Div pay-date | Jul 15 2024 |
Data delayed at least 15 minutes, as of Sep 20 2024 17:58 BST.
More ▼
Announcements
- XOMA Royalty to Present at Upcoming Investor Conferences in September
- XOMA Royalty Reports Second Quarter 2024 Financial Results and Highlights Recent Activities
- XOMA Declares Quarterly Preferred Stock Dividends
- XOMA Receives $8.1 Million Milestone Related to Day One Biopharmaceuticals’ Sale of its Priority Review Voucher
- XOMA to Present at H.C. Wainwright 2nd Annual Bioconnect Investor Conference at NASDAQ
- XOMA Reports First Quarter 2024 Financial Results and Highlights Recent Activities
- XOMA Adds Economic Interests in Three First-in-Category Assets to its Royalty and Milestone Portfolio Including XACIATO™ (clindamycin phosphate) Vaginal Gel 2%
- XOMA Earns $9 Million Milestone as FDA Grants Accelerated Approval to Day One’s OJEMDATM (tovorafenib) for Relapsed or Refractory BRAF-altered Pediatric Low-Grade Glioma (pLGG)
- XOMA Corporation Announces Closing of Tender Offer
- XOMA Announces Calculation of Additional Price Per Share and Extension of Expiration Date for Tender Offer for Kinnate Biopharma Inc.
More ▼